MapLight Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- MapLight Therapeutics's estimated annual revenue is currently $18.1M per year.
- MapLight Therapeutics's estimated revenue per employee is $155,000
- MapLight Therapeutics's total funding is $293M.
Employee Data
- MapLight Therapeutics has 117 Employees.
- MapLight Therapeutics grew their employee count by 27% last year.
MapLight Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Founder | Reveal Email/Phone |
3 | Founder | Reveal Email/Phone |
4 | Executive Assistant to the Chief Finance Officer, Chief Discovery Officer and General Councel | Reveal Email/Phone |
5 | Chief Financial Officer | Reveal Email/Phone |
6 | Chief Administrative and Accounting Officer | Reveal Email/Phone |
7 | Chief Administrative and Accounting Officer | Reveal Email/Phone |
8 | Chief Financial Officer | Reveal Email/Phone |
9 | Chief Financial Officer | Reveal Email/Phone |
10 | General Counsel | Reveal Email/Phone |
MapLight Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is MapLight Therapeutics?
Maplight is a biopharmaceutical company discovering and developing novel therapeutics for patients with disorders of the central nervous system (CNS).
keywords:N/A$293M
Total Funding
117
Number of Employees
$18.1M
Revenue (est)
27%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $11.7M | 117 | -8% | N/A |
#2 | $16.5M | 118 | -6% | N/A |
#3 | $17.1M | 118 | 22% | N/A |
#4 | $17.3M | 119 | -60% | N/A |
#5 | $38.7M | 119 | 35% | $193M |